Beijing Luzhu Biotechnology Future Growth
Future criteria checks 2/6
Beijing Luzhu Biotechnology is forecast to grow earnings and revenue by 47.5% and 59.7% per annum respectively. EPS is expected to grow by 19.3% per annum. Return on equity is forecast to be -403% in 3 years.
Key information
47.5%
Earnings growth rate
19.3%
EPS growth rate
| Biotechs earnings growth | 42.8% |
| Revenue growth rate | 59.7% |
| Future return on equity | -403.0% |
| Analyst coverage | Low |
| Last updated | 24 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 528 | -126 | -156 | -106 | 3 |
| 12/31/2025 | 67 | -349 | -331 | -268 | 3 |
| 12/31/2024 | 1 | -278 | -276 | -205 | 3 |
| 6/30/2024 | N/A | -280 | -235 | -167 | N/A |
| 3/31/2024 | N/A | -265 | -255 | -179 | N/A |
| 12/31/2023 | N/A | -249 | -276 | -190 | N/A |
| 9/30/2023 | N/A | -201 | -307 | -153 | N/A |
| 6/30/2023 | N/A | -152 | -339 | -117 | N/A |
| 3/31/2023 | N/A | -439 | -314 | -97 | N/A |
| 12/31/2022 | N/A | -725 | -289 | -77 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2480 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2480 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2480 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2480's revenue (59.7% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
High Growth Revenue: 2480's revenue (59.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2480 is forecast to be unprofitable in 3 years.